FDA inspection

SERIPHARM: FDA inspection ending May 6, 2016

FDA inspection 972558 · No Action Indicated (NAI) · Le Mans

Key facts

Inspection ID 972558
Firm SERIPHARM
FEI number 3002808119
Address Technopole Universite, 1 rue Democrite
City Le Mans
Country France
Fiscal year 2016
Inspection end date May 6, 2016
Classification No Action Indicated (NAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections